|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| C12Q 1/6886 | (2013.01) | ||
| C12Q2600/178 | (2013.01) |
| (11) | Number of the document | 2971094 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14717922.0 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/024128 |
| Date | 2014-03-12 |
| (87) | Number | WO 2014/150751 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361791945 P | 2013-03-15 | US | |
| 201361846178 P | 2013-07-15 | US |
| (72) |
JAGANI, Zainab , US
HOFFMAN, Gregory , US
STEGMEIER, Frank , US
MICKANIN, Craig , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | BIOMARKERS ASSOCIATED WITH BRM INHIBITION |
| BIOMARKERS ASSOCIATED WITH BRM INHIBITION |